Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
Sign Up to like & getrecommendations! Published in 2022 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izac135
Abstract: BACKGROUND Fecal microbiota transplantation (FMT) has been investigated as a treatment option for patients with inflammatory bowel disease with controversial results.We sought to perform a systematic review and meta-analysis to evaluate the benefit of FMT… read more here.
Keywords: fmt; remission; active ulcerative; ulcerative colitis ... See more keywords
Fecal microbiota transplantation for patients with active ulcerative colitis: A cost‐effectiveness analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.16015
Abstract: Growing studies have demonstrated clinical benefits of fecal microbiota transplantation (FMT) therapy (administered by colonoscopy, enema, or both) for active ulcerative colitis (UC). This study aimed to evaluate the cost‐effectiveness of standard treatment with and… read more here.
Keywords: microbiota transplantation; fecal microbiota; active ulcerative; ulcerative colitis ... See more keywords
Bilateral pulmonary embolism and pulmonary infarctions in active ulcerative colitis
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-249428
Abstract: Crohn’s disease and ulcerative colitis are inflammatory bowel diseases (IBDs) and they primarily involve the intestines and confer an increased risk of thromboembolism (TE). Here we report a case of a young man with active… read more here.
Keywords: pulmonary infarctions; active ulcerative; colitis; pulmonary embolism ... See more keywords
Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and Experimental Gastroenterology"
DOI: 10.2147/ceg.s367086
Abstract: Abstract This review addresses appropriate patient selection for upadacitinib, a Janus kinase inhibitor approved by the FDA and EMA for treatment of moderately to severely active ulcerative colitis (UC). Janus kinase molecules can contribute to the… read more here.
Keywords: patient selection; active ulcerative; severely active; ulcerative colitis ... See more keywords
Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice
Sign Up to like & getrecommendations! Published in 2017 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v23.i16.2995
Abstract: AIM To examine treatment decisions of gastroenterologists regarding the choice of prescribing 5-aminosalycilates (5ASA) with corticosteroids (CS) versus corticosteroids alone for patients with active ulcerative colitis (UC). METHODS A cross-sectional questionnaire exploring physicians’ attitude toward… read more here.
Keywords: combination; alone patients; corticosteroids alone; gastroenterology ... See more keywords